Inclusion Criteria:  A patient will be eligible for inclusion only if all of the following criteria are fulfilled:  Patients with any advanced gynecological malignancy and a life expectancy of approximately 4 months as estimated by their treating physician*. Potential patient groups include, but are not limited to, those with platinum-resistant/refractory recurrent epithelial ovarian cancer (PRR-EOC), metastatic/recurrent cervical or endometrial cancer progressing after platinum-based chemotherapy; high grade/undifferentiated metastatic uterine sarcoma progressing after first-line chemotherapy etc. Patients may be on active cancer treatment, about to commence active cancer treatment or under observation/palliative care. Age ≥ 18 years Able (both physically and cognitively) to complete patient-reported outcome measures independently in languages that are available in this study (i.e. without assistance from hospital translator).  Exclusion Criteria:  A patient will not be eligible for inclusion if any of the following criteria are fulfilled:  Unable to be comply with the protocol. A medical or psychological condition that limits the patient´s capacity to give informed consent, such as cognitive impairment, delirium, psychosis etc. Participation in another clinical trial.  A patient will be asked to appoint a carer.  Inclusion criteria carer:  Age ≥ 18 years A relative or close friend who is actively supporting the patient in her illness Able (both physically and cognitively) to complete questionnaires independently in languages that are available in this study (i.e. without assistance from hospital translator).  Exclusion criteria carer  A carer will not be eligible for inclusion if any of the following criteria are fulfilled:  Unable to be comply with the protocol A medical or psychological condition that limits the carer´s capacity to give informed consent, such as cognitive impairment, delirium, psychosis etc.